Regeneron Pharmaceuticals, Inc. (REGN)
49/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $69.6B
- P/E
- 16.5
- Sector Median P/E
- 25.5
- F-Score
- 5/9
- ROIC
- 1.5%
- FCF Yield
- 6.1%
REGN has a Tessera Quality Score of 49, placing it in the top 50% of the Healthcare sector. Its P/E of 16.5 is 35% below the Healthcare sector median (25.5). Piotroski F-Score is 5/9; trailing ROIC is 1.5%.
Sector Peers
- Vertex Pharmaceuticals Incorporated (VRTX)Mkt Cap: $134.0B · FCF: 30.3%
- Verona Pharma plc (VRNA)Mkt Cap: $72.7B · FCF: -43.6%
- argenx SE (ARGX)Mkt Cap: $54.8B · FCF: 12.0%
- Seagen Inc. (SGEN)Mkt Cap: $43.2B · FCF: -30.5%
- Alnylam Pharmaceuticals, Inc. (ALNY)Mkt Cap: $41.5B · FCF: 15.0%